top biopharmaceuticals for glp-1 medication North America Glucagon-like Peptide-1 Agonists Companies GLP-1 Receptor Agonist Market Valued

Innovent Biologics Inc

Semaglutide Injection

These appetite-suppressing treatments can help you manage hunger, support metabolic health, and make lasting progress

You receive: Personalized dosing plans Ongoing clinician support Transparent, predictable pricing Medication shipped directly to your door This allows more patients to access evidence-based weight loss support without brand-name medication pricing barriers

Nexa offers compounded GLP-1 (Semaglutide) prepared by licensed pharmacies for patients who qualify

We forecast one to two GLP-1 launches annually starting in 2026, with the first oral entrant expected by 2027